Cardiovascular disease burden in children with obesity: A narrative review

Sulafa K M Ali1, Bashir H Elnaem2, Mohamed A Abdullah3

  • 1Pediatric Cardiology, University of Sharjah, United Arab Emirates.

Insights

Childhood obesity is rising, increasing cardiovascular disease (CVD) risk. Current guidelines miss early, detectable stages of subclinical atherosclerosis in children, necessitating better diagnostic tools.

Area of Science:

  • Pediatric Cardiology
  • Public Health
  • Vascular Biology

Background:

  • Childhood obesity is a growing epidemic with early onset of cardiovascular disease (CVD).
  • Subclinical atherosclerosis, a precursor to CVD, begins in childhood and is potentially reversible.
  • Current CVD risk stratification guidelines for obese children lack diagnostic tests for early vascular changes.

Purpose of the Study:

  • To review the diagnosis and management of obesity-related CVD complications in children.
  • To highlight the need for incorporating subclinical atherosclerosis detection into clinical practice.
  • To identify potential diagnostic tools for early CVD detection in pediatric obesity.

Main Methods:

  • Comprehensive literature search (2010-2025) in PubMed and Cochrane Database.
  • Keywords included obesity, children, cardiovascular, subclinical atherosclerosis, vascular health, and cardiometabolic risk.
  • Data synthesis on diagnosis, management, and diagnostic tools for pediatric obesity and CVD.

Main Results:

  • Atherosclerosis has detectable, reversible stages in childhood, often missed by current guidelines.
  • Tools like carotid intima-media thickness and pulse wave velocity show links to obesity and cardiometabolic risk.
  • Lack of consensus hinders the routine use of these vascular health assessment tools in clinical care.

Conclusions:

  • Early detection of subclinical atherosclerosis in obese children is crucial for CVD prevention.
  • Existing guidelines need enhancement to include diagnostic methods for early vascular changes.
  • Further research is required to establish validated tools for routine clinical use in diagnosing subclinical CVD in pediatric obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
364
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
434
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
321
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
999